EUVIMEDEUVIMED entdecken
Open Access

Impact of Symptom Phenotype on Surgical Quality and Survival in Small‐Bowel Neuroendocrine Tumours: A Quality Metrics Analysis

Siddharth Darbhamulla iD, Krishna Kotecha iD, David L Chan, Kah Hoong Chang, Dale L Bailey, Nick Pavlakis, Stephen Clarke iD, Anthony J Gill, Anubhav Mittal iD, Jaswinder S Samra iD

Journal of Surgical Oncology · 2026-06 · 133 (7) · 926-933

DOI: 10.1002/jso.70245 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, online erschienen am 30.03.2026. Verfasst von Siddharth Darbhamulla und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Upper Gastrointestinal Surgery, Royal North Shore Hospital, St Leonards, New South Wales, Australia. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Intestinal Neoplasms, Intestine, Small. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is debate regarding the optimal management of small‐bowel neuroendocrine tumours (SBNETs), particularly concerning upfront resection in various clinical presentations. While symptom phenotypes are known to influence survival, their impact on technical surgical quality, especially in the emergency setting, remains poorly defined. This study evaluates whether symptom phenotype compromises the delivery of guideline‐concordant surgical care.

Methods

A retrospective analysis of 108 consecutive SBNET resections (2000–2023) at a specialized tertiary centre was performed. Patients were stratified into four phenotypes: obstructive/perforation ( n = 54), carcinoid syndrome (22), asymptomatic/incidental (22), and other symptoms (9). Operative metrics, including lymph‐node harvest (LNY) and margin status (R0/R1), were compared alongside overall survival (OS).

Results

Symptom phenotype was a predictor of operative urgency and approach. Obstructive cases required emergency surgery in 50% of instances compared to ≤ 11% in all other groups ( p < 0.001). Synchronous liver metastases were most prevalent in the carcinoid syndrome phenotype (50%) and lowest in the asymptomatic group (5%) ( p = 0.002). Despite these disparities in presentation and urgency, technical quality markers were uniform across all groups: median LNY ranged from 10 to 13 ( p = 0.426), R1/R2 margin rates were statistically similar ( p = 0.290), and median length of stay was 8 days for all cohorts ( p = 0.311). Multivariable analysis identified the asymptomatic phenotype as independently protective for OS (HR 0.42, p = 0.032), while liver metastasis was the strongest adverse prognostic factor (HR 3.25, p < 0.001).

Conclusions

Symptom phenotype dictates operative urgency and reflects disease burden but does not compromise the technical standards of surgery in a specialized unit. These findings suggest that high‐quality, guideline‐concordant lymphadenectomy is achievable even in emergency obstructive presentations, and correspondingly, access to specialized surgical oncology expertise may be sought even in obstructed patients to ensure technical quality is maintained.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsIntestinal NeoplasmsIntestine, SmallHumansFemaleRetrospective StudiesMalePhenotypeMiddle AgedAgedSurvival RateLymph Node ExcisionPrognosisAdult

Stichwörter der Autor:innen

R0 resectionemergency surgerylymphadenectomysmall‐bowel neuroendocrine tumoursurvival

Autor:innen und Institutionen

  • Department of Upper Gastrointestinal Surgery, Royal North Shore Hospital, St Leonards, New South Wales, Australia.
  • Northern Clinical School, Faculty of Medicine & Health, University of Sydney, Sydney, Australia.
  • Department of Medical Oncology, Royal North Shore Hospital, Sydney, Australia.
  • Department of Colorectal Surgery, Royal North Shore Hospital, Sydney, Australia.
  • Department of Nuclear Medicine, Royal North Shore Hospital, Sydney, Australia.
  • NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards, New South Wales, Australia.

ORCID-Profile: Siddharth Darbhamulla, Krishna Kotecha, Stephen Clarke, Anubhav Mittal, Jaswinder S Samra

Zitieren

APA

Darbhamulla, S., Kotecha, K., Chan, D. L., Chang, K. H., Bailey, D. L., Pavlakis, N., Clarke, S., Gill, A. J., Mittal, A., & Samra, J. S. (2026). Impact of Symptom Phenotype on Surgical Quality and Survival in Small‐Bowel Neuroendocrine Tumours: A Quality Metrics Analysis. Journal of Surgical Oncology, 133(7), 926-933. https://doi.org/10.1002/jso.70245

Vancouver

Darbhamulla S, Kotecha K, Chan DL, Chang KH, Bailey DL, Pavlakis N, et al. Impact of Symptom Phenotype on Surgical Quality and Survival in Small‐Bowel Neuroendocrine Tumours: A Quality Metrics Analysis. Journal of Surgical Oncology. 2026;133(7):926-933. doi:10.1002/jso.70245

BibTeX
@article{Darbhamulla2026,
  author = {Darbhamulla, Siddharth and Kotecha, Krishna and Chan, David L and Chang, Kah Hoong and Bailey, Dale L and Pavlakis, Nick and Clarke, Stephen and Gill, Anthony J and Mittal, Anubhav and Samra, Jaswinder S},
  title = {Impact of Symptom Phenotype on Surgical Quality and Survival in Small‐Bowel Neuroendocrine Tumours: A Quality Metrics Analysis},
  journal = {Journal of Surgical Oncology},
  year = {2026},
  volume = {133},
  number = {7},
  pages = {926--933},
  doi = {10.1002/jso.70245}
}
Kostenlos starten →